Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. (Q36615019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

C L Shields

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

E M Fulco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J D Arias

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

C Alarcon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

P Rishi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Kaliki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

C G Bianciotto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J A Shields

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

21 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

253-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation

13 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Fibrin sealant for retinoblastoma: where are we?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Retinoblastoma: one world, one vision

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Intraocular retinoblastoma: the case for a new group classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

The evaluation and current concept of retinoblastoma therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemotherapy plus local treatment in the management of intraocular retinoblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemoreduction in the initial management of intraocular retinoblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Presenting signs of retinoblastoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Trials of intravitreal injections of chemotherapeutic agents in rabbits.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

A cautionary tale: dosing chemotherapy in infants with retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Clinical presentation and outcome of retinoblastoma among children treated at the National Cancer Institute (NCI) in Gezira, Sudan: a single Institution experience

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Long-term visual outcome following chemoreduction for retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Periocular chemotherapy for retinoblastoma: success with problems?

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Practical approach to management of retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemoreduction for Retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Trends in the management of retinoblastoma: evaluation of 1,196 consecutive eyes during 1974 to 2001.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Postenucleation adjuvant therapy in high-risk retinoblastoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3574237

Retinoblastoma in the Beijing Tongren Hospital from 1957 to 2006: clinicopathological findings

20 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2012.175

Retinal nerve fiber layer analysis in the diagnosis of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2012.175

Reconstruction with rectus abdominis myocutaneous free flap after orbital exenteration in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2012.175

Basic understanding of current classification and management of retinoblastoma

21 January 2018

1 reference

12 December 2020

Intraocular concentrations of chemotherapeutic agents after systemic or local administration

1 reference

12 December 2020

Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications

1 reference

12 December 2020

Retinoblastoma therapy delivers power of chemotherapy with surgical precision

1 reference

12 December 2020

Superselective intraophthalmic artery chemotherapy: what we do not know

1 reference

12 December 2020

Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma

1 reference

12 December 2020

Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds

1 reference

12 December 2020

Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.

1 reference

12 December 2020

[Study on conservative treatment of retinoblastoma--effect of intravitreal injection of melphalan on the rabbit retina]

1 reference

12 December 2020

Intravitreal methotrexate for retinoblastoma

1 reference

12 December 2020

Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma

1 reference

12 December 2020

The International Classification of Retinoblastoma predicts chemoreduction success

1 reference

12 December 2020

The burden of age-related macular degeneration: a value-based analysis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2012.175

7 January 2021

inferred from DOI database lookup

Clinicopathologic reports, case reports, and small case series: rapidly progressive T-cell lymphoma of the conjunctiva

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2012.175

7 January 2021

inferred from DOI database lookup

Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2012.175

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/EYE.2012.175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

22995941

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22995941%20AND%20SRC:MED&resulttype=core&format=json